DGX.US Quest Diagnostics Incorporated

Healthcare Health Care Providers & Services USA Stocks
259.60 USD
Close of Nov 13, 2026
168.34 262.00
Market cap
USD 28.6B
P/E
25.9x
P/B
3.74x
ROE
15.4%
Dividend yield
1.24%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DGX.US undervalued?

Graham number
Price259.60
Graham value125.17
Premium107.4%

DGX.US trades 107.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Quest Diagnostics Incorporated fundamental analysis

No fundamental analysis for Quest Diagnostics Incorporated yet.

Quest Diagnostics Incorporated stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consum…

Full company profile